171 – 180 of 326
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Antithrombotic therapy in atrial fibrillation : stop triple therapy and start optimizing dual therapy?
- Contribution to journal › Letter
-
Mark
Survival of Patients With Angina Pectoris Undergoing Percutaneous Coronary Intervention With Intracoronary Pressure Wire Guidance
- Contribution to journal › Article
-
Mark
Early repolarization pattern on ECG recorded before the acute coronary event does not predict ventricular fibrillation during ST-elevation myocardial infarction
- Contribution to journal › Article
-
Mark
Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction : a VALIDATE-SWEDEHEART substudy
- Contribution to journal › Article
-
Mark
Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
- Contribution to journal › Article
-
Mark
Inhibition of the long non-coding RNA NEAT1 protects cardiomyocytes from hypoxia in vitro via decreased pri-miRNA processing
- Contribution to journal › Article
-
Mark
Methods for isolation and transcriptional profiling of individual cells from the human heart
- Contribution to journal › Article
-
Mark
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic
- Contribution to journal › Article
-
Mark
Temporal trends in bleeding events in acutemyocardial infarction : Insights from the SWEDEHEARTregistry
- Contribution to journal › Article
-
Mark
Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction : Rationale and Methodology
- Contribution to journal › Letter
